HRP20180176T1 - Spojevi korisni u sintezi spojeva benzamida - Google Patents

Spojevi korisni u sintezi spojeva benzamida Download PDF

Info

Publication number
HRP20180176T1
HRP20180176T1 HRP20180176TT HRP20180176T HRP20180176T1 HR P20180176 T1 HRP20180176 T1 HR P20180176T1 HR P20180176T T HRP20180176T T HR P20180176TT HR P20180176 T HRP20180176 T HR P20180176T HR P20180176 T1 HRP20180176 T1 HR P20180176T1
Authority
HR
Croatia
Prior art keywords
compound according
compounds
cclh2
ccl2h
cfh2
Prior art date
Application number
HRP20180176TT
Other languages
English (en)
Inventor
Mario Emilov Lozanov
Anthony Frank Skufca
Andrew George Zeiler
Original Assignee
Resverlogix Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resverlogix Corp. filed Critical Resverlogix Corp.
Publication of HRP20180176T1 publication Critical patent/HRP20180176T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (15)

1. Spoj Formule I: [image] Formula I gdje: R1 se bira između Br i CN; R2 je odabran između H i Br; R3 je odabran između H i [image] gdje: R se bira između H, CH3, CF3, CF2H, CFH2, CCl3, CCl2H, CClH2, CBr3, CBr2H i CBrH2; i X se bira između O i S; pod uvjetom da: kada R1 je CN, tada R2 je H; i kada R1 je Br, tada R3 je [image] i pri čemu ako R1 je Br i R2 je H, tada R3 je [image] gdje se R bira između CF3, CF2H, CFH2, CCl3, CCl2H, CClH2, CBr3, CBr2H i CBrH2; i X se bira između O i S.
2. Spoj sukladno patentnom zahtjevu 1, gdje: R1 je Br; R2 je H; R3 je [image] gdje R se bira između CF3, CF2H, CFH2, CCl3, CCl2H, CClH2, CBr3, CBr2H i CBrH2; i X se bira između O i S.
3. Spoj sukladno patentnom zahtjevu 1, gdje: R1 je Br; R2 je Br; R3 je [image] gdje R se bira između H, CH3, CF3, CF2H, CFH2, CCl3, CCl2H, CClH2, CBr3, CBr2H i CBrH2; i X se bira između O i S.
4. Spoj sukladno patentnom zahtjevu 1, gdje: R1 je CN; R2 je H; R3 je [image] gdje R se bira između H, CH3, CF3, CF2H, CFH2, CCl3, CCl2H, CClH2, CBr3, CBr2H i CBrH2; i X se bira između O i S.
5. Spoj sukladno patentnom zahtjevu 1, naznačeno time, da je spoj odabrano između: 2-bromo-3,5-dimetoksitrifluoroacetanilida, 2, 4-dibromo-3,5-dimetoksitrifluoroacetanilida, 2-cijano-3,5-dimetoksitrifluoroacetanilida, i 2-amino-4,6-dimetoksibenzonitrila.
6. Spoj sukladno patentnom zahtjevu 2, naznačeno time, da je X kisik.
7. Spoj sukladno patentnom zahtjevu 3, naznačeno time, da je X kisik.
8. Spoj sukladno patentnom zahtjevu 4, naznačeno time, da je X kisik.
9. Spoj sukladno patentnom zahtjevu 2, naznačeno time, da je R odabran od CF3, CF2H, CFH2, CCl3, CCl2H, i CClH2.
10. Spoj sukladno patentnom zahtjevu 3, naznačeno time da je R odabran od CF3, CF2H, CFH2, CCl3, CCl2H, i CClH2.
11. Spoj sukladno patentnom zahtjevu 4, naznačeno time, da je R odabran od CF3, CF2H, CFH2, CCl3, CCl2H, i CClH2.
12. Spoj sukladno patentnom zahtjevu 5, naznačeno time, da je spoj 2-bromo-3,5-dimetoksitrifluoroacetanilid.
13. Spoj sukladno patentnom zahtjevu 5, naznačeno time, da je spoj 2,4-dibromo-3,5-dimetoksitrifluoroacetanilid.
14. Spoj sukladno patentnom zahtjevu 5, naznačeno time, da je spoj 2-cijano-3,5-dimetoksitrifluoroacetanilid.
15. Spoj sukladno patentnom zahtjevu 5, naznačeno time, da je spoj 2-amino-4,6-dimetoksibenzonitril.
HRP20180176TT 2012-10-15 2018-01-30 Spojevi korisni u sintezi spojeva benzamida HRP20180176T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261713711P 2012-10-15 2012-10-15
PCT/IB2013/003031 WO2014060852A2 (en) 2012-10-15 2013-10-09 Compounds useful in the synthesis of benzamide compounds
EP13846466.4A EP2906531B1 (en) 2012-10-15 2013-10-09 Compounds useful in the synthesis of benzamide compounds

Publications (1)

Publication Number Publication Date
HRP20180176T1 true HRP20180176T1 (hr) 2018-03-09

Family

ID=50475926

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180176TT HRP20180176T1 (hr) 2012-10-15 2018-01-30 Spojevi korisni u sintezi spojeva benzamida

Country Status (26)

Country Link
US (1) US8884046B2 (hr)
EP (1) EP2906531B1 (hr)
JP (2) JP6307087B2 (hr)
KR (1) KR101532570B1 (hr)
CN (1) CN104884427B (hr)
AU (1) AU2013333575B2 (hr)
BR (1) BR112015008389B1 (hr)
CA (1) CA2888378C (hr)
CY (1) CY1119862T1 (hr)
DK (1) DK2906531T3 (hr)
ES (1) ES2658221T3 (hr)
HK (1) HK1207623A1 (hr)
HR (1) HRP20180176T1 (hr)
HU (1) HUE036421T2 (hr)
IL (2) IL238186A (hr)
LT (1) LT2906531T (hr)
MX (1) MX338885B (hr)
NO (1) NO2992016T3 (hr)
NZ (1) NZ707276A (hr)
PL (1) PL2906531T3 (hr)
PT (1) PT2906531T (hr)
RS (1) RS56846B1 (hr)
RU (1) RU2593752C1 (hr)
SA (1) SA515360284B1 (hr)
SI (1) SI2906531T1 (hr)
WO (1) WO2014060852A2 (hr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
BRPI1009315B8 (pt) 2009-03-18 2021-05-25 Resverlogix Corp composto anti-flamatórios e suas composições farmacêuticas
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
PL2773354T3 (pl) 2011-11-01 2019-12-31 Resverlogix Corp. Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118752D0 (en) * 2001-08-01 2001-09-26 Pfizer Ltd Process for the production of quinazolines
GB0206033D0 (en) * 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
US20040033480A1 (en) 2002-08-15 2004-02-19 Wong Norman C.W. Use of resveratrol to regulate expression of apolipoprotein A1
US20050080024A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20050080021A1 (en) 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
CA2541590A1 (en) 2003-10-10 2005-04-21 Resverlogix Corp. Treatment of diseases associated with the egr-1 enhancer element
GB0512324D0 (en) * 2005-06-16 2005-07-27 Novartis Ag Organic compounds
EP1838296B1 (en) 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP2314295B1 (en) 2005-07-29 2015-01-28 Resverlogix, Inc Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) * 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
MX2009013781A (es) * 2007-06-21 2010-02-01 Irm Llc Inhibidores de cinasa de proteina y metodos para el uso de los mismos.
PT2346837E (pt) 2008-06-26 2015-04-02 Resverlogix Corp Métodos de preparação de derivados de quinazolinona
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
BRPI1009315B8 (pt) 2009-03-18 2021-05-25 Resverlogix Corp composto anti-flamatórios e suas composições farmacêuticas
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
GB201007286D0 (en) * 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
DE102010048800A1 (de) * 2010-10-20 2012-05-10 Merck Patent Gmbh Chinoxalinderivate
PL2773354T3 (pl) 2011-11-01 2019-12-31 Resverlogix Corp. Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów
CA2886973C (en) * 2012-10-15 2017-08-15 Albemarle Corporation Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
TWI641936B (zh) * 2012-11-13 2018-11-21 美商慧盛材料美國責任有限公司 漿料供應及/或化學品摻合物供應設備、方法、使用方法及製造方法

Also Published As

Publication number Publication date
CN104884427B (zh) 2016-09-07
KR20150061661A (ko) 2015-06-04
RS56846B1 (sr) 2018-04-30
DK2906531T3 (en) 2018-02-05
KR101532570B1 (ko) 2015-06-30
EP2906531B1 (en) 2018-01-17
JP2015531403A (ja) 2015-11-02
CA2888378C (en) 2015-09-22
IL244099A0 (en) 2016-04-21
US20140107369A1 (en) 2014-04-17
HUE036421T2 (hu) 2018-07-30
SA515360284B1 (ar) 2016-04-19
HK1207623A1 (en) 2016-02-05
BR112015008389B1 (pt) 2020-12-15
JP6307087B2 (ja) 2018-04-04
CY1119862T1 (el) 2018-06-27
AU2013333575A1 (en) 2015-05-28
BR112015008389A2 (pt) 2017-07-04
ES2658221T3 (es) 2018-03-08
SI2906531T1 (en) 2018-03-30
WO2014060852A3 (en) 2014-07-24
WO2014060852A2 (en) 2014-04-24
US8884046B2 (en) 2014-11-11
MX338885B (es) 2016-05-04
PT2906531T (pt) 2018-02-06
RU2593752C1 (ru) 2016-08-10
LT2906531T (lt) 2018-02-26
MX2015004764A (es) 2015-08-14
AU2013333575B2 (en) 2015-07-16
IL238186A (en) 2016-03-31
EP2906531A4 (en) 2016-06-01
NO2992016T3 (hr) 2018-03-17
CN104884427A (zh) 2015-09-02
CA2888378A1 (en) 2014-04-24
EP2906531A2 (en) 2015-08-19
JP2017088632A (ja) 2017-05-25
NZ707276A (en) 2016-02-26
PL2906531T3 (pl) 2018-04-30

Similar Documents

Publication Publication Date Title
HRP20180176T1 (hr) Spojevi korisni u sintezi spojeva benzamida
HRP20161103T1 (hr) Kemijski spojevi
HRP20171175T1 (hr) Novi triciklički spojevi
RS53301B (en) TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
RS53688B1 (en) 1,2,5-OXADIAZOLES AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
RS54485B1 (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
HRP20160001T1 (hr) Postupak za pripravu fenil supstituiranih n-metoksi-[1-metil-2-feniletil]amida 3-difluorometil-1-metil-1h-pirazol-4-karboksilne kiseline
WO2011123536A8 (en) Polycyclic tetracycline compounds
EA201492255A1 (ru) Феноксиэтилпиперидиновые соединения
WO2014054058A8 (en) Novel compounds, their synthesis and their uses
WO2014036502A8 (en) Tetracycline compounds
RS52171B (en) NALMEFEN DI-ESTER PRODUCTS
RS53940B1 (en) HETEROARYL UNITS AS LIGANDS OF 5-HT4 RECEPTORS
WO2010129057A3 (en) Tetracycline compounds
WO2011025982A3 (en) Tetracycline compounds
ME01144B (me) 3-aminociklopentankarboksamidi kao modulatori hemokin receptora
AR073008A1 (es) Compuestos de 2- aminopirimidina como potentes inhibidores de hsp-90
MX363685B (es) Una sintesis telescopica de sal de 5-amino-4-nitro-1-alquil-1h-pir azol.
RS54001B1 (en) SUBSTITUTED [(5H-Pyrrolo [2,1-C] [1,4] BENZODIAZEPIN-11-IL-) PIPERAZIN-1-IL] -2,2-DIMETHYLPROPANOIC ACID COMPOUNDS HT 2A
CR20130029A (es) Compuestos de tiofeno 2,3,5-trisustituidos y usos de los mismos
TH96530B (th) สูตรผสม
EA201300177A1 (ru) Составы
UA96477U (xx) ЗАСТОСУВАННЯ ЦИС-ТЕТРАГАЛОГЕНОДИ-μ-АДАМАНТИЛКАРБОКСИЛАТИ ДИРЕНІЮ (ІІІ), ЯК СПОЛУК, ЩО ПРОЯВЛЯЮТЬ ГЕПАТОПРОТЕКТОРНУ ТА ГЕПАТОМОДУЛЮЮЧУ АКТИВНІСТЬ
RS54314B1 (en) (S) -2-AMINO-3-CYCLOHEXYLPROPANIC ACID DERIVATIVES, THEIR PRODUCTION AND USE